Company / Book Value per Share
VYNE Therapeutics Inc. Book Value per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$5.983
FY2025
5-year range
$0.868 / $16.34
FY2021-FY2025
Trend
-4.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Book Value per Share has declined for 3 consecutive years, from $16.34 in FY2022 to $5.983 in FY2025.
Based on SEC 10-K filings.
$5.983 in FY2025 with a 5-year CAGR of +25.4%.
Declined from $9.661 to $5.983 over the past 2 years.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -28.5%
- 5-Year CAGR
- +25.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- VYNE Therapeutics Inc.'s book value per share has declined for 3 consecutive years.
- 5-year CAGR of +25.4%, indicating consistent growth.
- In FY2025, book value per share decreased 4.9% year-over-year.
- Peak book value per share was recorded in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -3.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.983 | -4.9% |
| FY2024 | $6.294 | -34.9% |
| FY2023 | $9.661 | -40.9% |
| FY2022 | $16.34 | +1782.9% |
| FY2021 | $0.868 | -55.0% |
| FY2020 | $1.927 | +178.5% |
| FY2019 | -$2.455 | +55.8% |
| FY2018 | -$5.556 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026